Publication Details
Abstract
The pharmaceutical management of type 2 diabetes: therapeutic challenges and improvements in Uzbekistan and Germany — a paper using a multicountry World Health Organization assessment The diabetes situation is more favourable in Germany as modern diabetes therapies are easily available owing to the higher level of the healthcare system in Germany, whilst in Uzbekistan, diabetes was hard to treat due to insufficient resource and non-prevalent access to pharmaceuticals. The review analyzes current pharmaceutical options, challenges to treatment in each country, and innovative strategies being utilized. It also explores the differences in healthcare systems, laws, and access to drugs. The studies are looking to provide relevant data that may improve diabetes management in low-resource settings and perhaps have global implications.